In a first, five Indian pharma majors have joined hands to conduct phase-III clinical trials of investigational anti-viral drug Molnupiravir on mild Covid-19 patients. The companies include Dr Reddy's Laboratories Ltd, Cipla Ltd, Sun Pharmaceutical Industries Ltd, Torrent Pharmaceuticals Ltd and Emcure Pharmaceuticals Ltd.
from Times of India https://ift.tt/3qzK8pO
https://ift.tt/eA8V8J
Tuesday, June 29, 2021
In a first, 5 Indian pharma majors ally for Covid drug trials
About News Monastery
Soratemplates is a blogger resources site is a provider of high quality blogger template with premium looking layout and robust design
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment